CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 91  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0753
LYS 10.0066
GLU 20.0079
LEU 30.0075
ARG 40.0139
CYS 50.0145
GLN 60.0246
CYS 70.0338
ILE 80.0136
LYS 90.0188
THR 100.0174
TYR 110.0136
SER 120.0287
LYS 130.0459
PRO 140.0192
PHE 150.0139
HIS 160.0315
PRO 170.0263
LYS 180.0369
PHE 190.0208
ILE 200.0087
LYS 210.0163
GLU 220.0123
LEU 230.0161
ARG 240.0060
VAL 250.0106
ILE 260.0201
GLU 270.0251
SER 280.0063
GLY 290.0265
PRO 300.0263
HIS 310.0137
CYS 320.0069
ALA 330.0219
ASN 340.0121
THR 350.0175
GLU 360.0179
ILE 370.0098
ILE 380.0081
VAL 390.0059
LYS 400.0166
LEU 410.0190
SER 420.0183
ASP 430.0456
GLY 440.0305
ARG 450.0162
GLU 460.0244
LEU 470.0179
CYS 480.0200
LEU 490.0127
ASP 500.0266
PRO 510.0230
LYS 520.0210
GLU 530.0149
ASN 540.0255
TRP 550.0161
VAL 560.0078
GLN 570.0084
ARG 580.0243
VAL 590.0192
VAL 600.0212
GLU 610.0252
LYS 620.0078
PHE 630.0098
LEU 640.0186
LYS 650.0367
ARG 660.0293
ALA 670.0395
GLU 680.0238
ASN 690.0753

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.